17386-10-6,
4-(Piperidin-1-ylmethyl)thiazol-2-amine,
4-Piperidin-1-ylmethyl-thiazol-2-ylamine,
4-(piperidin-1-ylmethyl)-1,3-thiazol-2-amine,
2-thiazolamine, 4-(1-piperidinylmethyl)-,
SMR000063541,
MLS000056640,
4-(1-Piperidinylmethyl)-1,3-thiazol-2-amine,
4-[(piperidin-1-yl)methyl]-1,3-thiazol-2-amine,
AC1LGANN,
AC1Q4VPC,
AC1Q52QD,
Oprea1_373130,
Oprea1_461382,
cid_767904,
SCHEMBL3632268,
CHEMBL1423163,
BDBM33536,
CTK4D4787,
KS-00003KLB,
DTXSID70354284,
HMS1675C10,
HMS2357G05,
ZINC246273,
ANW-53054,
STK115031,
AKOS000713715,
FS-1969,
MCULE-1790405973,
4-(1-piperidinylmethyl)-2-thiazolamine,
[4-(piperidinomethyl)thiazol-2-yl]amine,
2-Thiazolamine,4-(1-piperidinylmethyl)-,
AJ-18325,
BAS 01277230,
TR-007707,
4-(piperidylmethyl)-1,3-thiazole-2-ylamine,
BB 0253898,
FT-0677049,
ST24043132,
ST45072742,
EN300-10057,
L-4490,
SR-01000508303,
I05-2209,
J-513822,
SR-01000508303-1,
Z96092811,
F0903-2241,
4-(1-Piperidinylmethyl)-1,3-thiazol-2-amine, AldrichCPR,
4-Piperidin-1-ylmethyl-thiazol-2-ylamine;2-Thiazolamine, 4-(1-piperidinylmethyl)-,
AR-1E5532,
CID767904,
17471-12-4,